Chickenpox vaccine, also known as varicella vaccine, is a vaccine that protects against chickenpox.One dose of this vaccine prevents 100% of severe disease and 95% of moderate disease. Varicella vaccine is made up of Oka strain of live attenuated virus. This vaccine is safe and constitutes rare severe side effects. Moreover, varicella vaccine is 7090% effective in preventing varicella. We mainly focus on live attenuated varicella vaccine in this report.

The global Chickenpox Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Chickenpox Vaccine in various end use industries. The expanding demands from the Kids Injection and Adults Injection, are propelling Chickenpox Vaccine market. Monovalent Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Combination Vaccine segment is estimated at % CAGR for the next seven-year period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chickenpox Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Chickenpox Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Chickenpox Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chickenpox Vaccine sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Chickenpox Vaccine covered in this report include Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross and Biken, etc.

The global Chickenpox Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Merck

GSK

Shanghai Institute

BCHT

Changsheng

Keygen

Green Cross

Biken

Scope of Chickenpox Vaccine - Market Report

Report Metric	Details
Report Name	Chickenpox Vaccine - Market
CAGR	5%
Global Chickenpox Vaccine market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chickenpox Vaccine market, Segment by Type:	Monovalent Vaccine Combination Vaccine
Global Chickenpox Vaccine market, by Application	Kids Injection Adults Injection
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Chickenpox Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Chickenpox Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Chickenpox Vaccine - Market report?

Ans: The Applications covered in the Chickenpox Vaccine - Market report are Kids Injection, Adults Injection

What are the Type segmentation covered in the Chickenpox Vaccine - Market report?

Ans: The Types covered in the Chickenpox Vaccine - Market report are Monovalent Vaccine, Combination Vaccine

1 Chickenpox Vaccine Market Overview

1.1 Chickenpox Vaccine Product Overview

1.2 Chickenpox Vaccine Market Segment by Type

1.2.1 Monovalent Vaccine

1.2.2 Combination Vaccine

1.3 Global Chickenpox Vaccine Market Size by Type

1.3.1 Global Chickenpox Vaccine Market Size Overview by Type (2018-2029)

1.3.2 Global Chickenpox Vaccine Historic Market Size Review by Type (2018-2023)

1.3.3 Global Chickenpox Vaccine Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Chickenpox Vaccine Sales Breakdown by Type (2018-2023)

1.4.2 Europe Chickenpox Vaccine Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Chickenpox Vaccine Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Chickenpox Vaccine Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Chickenpox Vaccine Sales Breakdown by Type (2018-2023)

2 Global Chickenpox Vaccine Market Competition by Company

2.1 Global Top Players by Chickenpox Vaccine Sales (2018-2023)

2.2 Global Top Players by Chickenpox Vaccine Revenue (2018-2023)

2.3 Global Top Players by Chickenpox Vaccine Price (2018-2023)

2.4 Global Top Manufacturers Chickenpox Vaccine Manufacturing Base Distribution, Sales Area, Product Type

2.5 Chickenpox Vaccine Market Competitive Situation and Trends

2.5.1 Chickenpox Vaccine Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Chickenpox Vaccine Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chickenpox Vaccine as of 2022)

2.7 Date of Key Manufacturers Enter into Chickenpox Vaccine Market

2.8 Key Manufacturers Chickenpox Vaccine Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Chickenpox Vaccine Status and Outlook by Region

3.1 Global Chickenpox Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Chickenpox Vaccine Historic Market Size by Region

3.2.1 Global Chickenpox Vaccine Sales in Volume by Region (2018-2023)

3.2.2 Global Chickenpox Vaccine Sales in Value by Region (2018-2023)

3.2.3 Global Chickenpox Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Chickenpox Vaccine Forecasted Market Size by Region

3.3.1 Global Chickenpox Vaccine Sales in Volume by Region (2024-2029)

3.3.2 Global Chickenpox Vaccine Sales in Value by Region (2024-2029)

3.3.3 Global Chickenpox Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Chickenpox Vaccine by Application

4.1 Chickenpox Vaccine Market Segment by Application

4.1.1 Kids Injection

4.1.2 Adults Injection

4.2 Global Chickenpox Vaccine Market Size by Application

4.2.1 Global Chickenpox Vaccine Market Size Overview by Application (2018-2029)

4.2.2 Global Chickenpox Vaccine Historic Market Size Review by Application (2018-2023)

4.2.3 Global Chickenpox Vaccine Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Chickenpox Vaccine Sales Breakdown by Application (2018-2023)

4.3.2 Europe Chickenpox Vaccine Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Chickenpox Vaccine Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Chickenpox Vaccine Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Chickenpox Vaccine Sales Breakdown by Application (2018-2023)

5 North America Chickenpox Vaccine by Country

5.1 North America Chickenpox Vaccine Historic Market Size by Country

5.1.1 North America Chickenpox Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Chickenpox Vaccine Sales in Volume by Country (2018-2023)

5.1.3 North America Chickenpox Vaccine Sales in Value by Country (2018-2023)

5.2 North America Chickenpox Vaccine Forecasted Market Size by Country

5.2.1 North America Chickenpox Vaccine Sales in Volume by Country (2024-2029)

5.2.2 North America Chickenpox Vaccine Sales in Value by Country (2024-2029)

6 Europe Chickenpox Vaccine by Country

6.1 Europe Chickenpox Vaccine Historic Market Size by Country

6.1.1 Europe Chickenpox Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Chickenpox Vaccine Sales in Volume by Country (2018-2023)

6.1.3 Europe Chickenpox Vaccine Sales in Value by Country (2018-2023)

6.2 Europe Chickenpox Vaccine Forecasted Market Size by Country

6.2.1 Europe Chickenpox Vaccine Sales in Volume by Country (2024-2029)

6.2.2 Europe Chickenpox Vaccine Sales in Value by Country (2024-2029)

7 Asia-Pacific Chickenpox Vaccine by Region

7.1 Asia-Pacific Chickenpox Vaccine Historic Market Size by Region

7.1.1 Asia-Pacific Chickenpox Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Chickenpox Vaccine Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Chickenpox Vaccine Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Chickenpox Vaccine Forecasted Market Size by Region

7.2.1 Asia-Pacific Chickenpox Vaccine Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Chickenpox Vaccine Sales in Value by Region (2024-2029)

8 Latin America Chickenpox Vaccine by Country

8.1 Latin America Chickenpox Vaccine Historic Market Size by Country

8.1.1 Latin America Chickenpox Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Chickenpox Vaccine Sales in Volume by Country (2018-2023)

8.1.3 Latin America Chickenpox Vaccine Sales in Value by Country (2018-2023)

8.2 Latin America Chickenpox Vaccine Forecasted Market Size by Country

8.2.1 Latin America Chickenpox Vaccine Sales in Volume by Country (2024-2029)

8.2.2 Latin America Chickenpox Vaccine Sales in Value by Country (2024-2029)

9 Middle East and Africa Chickenpox Vaccine by Country

9.1 Middle East and Africa Chickenpox Vaccine Historic Market Size by Country

9.1.1 Middle East and Africa Chickenpox Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Chickenpox Vaccine Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Chickenpox Vaccine Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Chickenpox Vaccine Forecasted Market Size by Country

9.2.1 Middle East and Africa Chickenpox Vaccine Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Chickenpox Vaccine Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Merck

10.1.1 Merck Company Information

10.1.2 Merck Introduction and Business Overview

10.1.3 Merck Chickenpox Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Merck Chickenpox Vaccine Products Offered

10.1.5 Merck Recent Development

10.2 GSK

10.2.1 GSK Company Information

10.2.2 GSK Introduction and Business Overview

10.2.3 GSK Chickenpox Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.2.4 GSK Chickenpox Vaccine Products Offered

10.2.5 GSK Recent Development

10.3 Shanghai Institute

10.3.1 Shanghai Institute Company Information

10.3.2 Shanghai Institute Introduction and Business Overview

10.3.3 Shanghai Institute Chickenpox Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Shanghai Institute Chickenpox Vaccine Products Offered

10.3.5 Shanghai Institute Recent Development

10.4 BCHT

10.4.1 BCHT Company Information

10.4.2 BCHT Introduction and Business Overview

10.4.3 BCHT Chickenpox Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.4.4 BCHT Chickenpox Vaccine Products Offered

10.4.5 BCHT Recent Development

10.5 Changsheng

10.5.1 Changsheng Company Information

10.5.2 Changsheng Introduction and Business Overview

10.5.3 Changsheng Chickenpox Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Changsheng Chickenpox Vaccine Products Offered

10.5.5 Changsheng Recent Development

10.6 Keygen

10.6.1 Keygen Company Information

10.6.2 Keygen Introduction and Business Overview

10.6.3 Keygen Chickenpox Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Keygen Chickenpox Vaccine Products Offered

10.6.5 Keygen Recent Development

10.7 Green Cross

10.7.1 Green Cross Company Information

10.7.2 Green Cross Introduction and Business Overview

10.7.3 Green Cross Chickenpox Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Green Cross Chickenpox Vaccine Products Offered

10.7.5 Green Cross Recent Development

10.8 Biken

10.8.1 Biken Company Information

10.8.2 Biken Introduction and Business Overview

10.8.3 Biken Chickenpox Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Biken Chickenpox Vaccine Products Offered

10.8.5 Biken Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Chickenpox Vaccine Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Chickenpox Vaccine Industrial Chain Analysis

11.4 Chickenpox Vaccine Market Dynamics

11.4.1 Chickenpox Vaccine Industry Trends

11.4.2 Chickenpox Vaccine Market Drivers

11.4.3 Chickenpox Vaccine Market Challenges

11.4.4 Chickenpox Vaccine Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Chickenpox Vaccine Distributors

12.3 Chickenpox Vaccine Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Major Company of Monovalent Vaccine

Table 2. Major Company of Combination Vaccine

Table 3. Global Chickenpox Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 4. Global Chickenpox Vaccine Sales by Type (2018-2023) & (K Doses)

Table 5. Global Chickenpox Vaccine Sales Market Share in Volume by Type (2018-2023)

Table 6. Global Chickenpox Vaccine Sales by Type (2018-2023) & (US& Million)

Table 7. Global Chickenpox Vaccine Market Share in Value by Type (2018-2023)

Table 8. Global Chickenpox Vaccine Price by Type (2018-2023) & (USD/Dose)

Table 9. Global Chickenpox Vaccine Sales by Type (2024-2029) & (K Doses)

Table 10. Global Chickenpox Vaccine Sales Market Share in Volume by Type (2024-2029)

Table 11. Global Chickenpox Vaccine Sales by Type (2024-2029) & (US$ Million)

Table 12. Global Chickenpox Vaccine Sales Market Share in Value by Type (2024-2029)

Table 13. Global Chickenpox Vaccine Price by Type (2024-2029) & (USD/Dose)

Table 14. North America Chickenpox Vaccine Sales by Type (2018-2023) & (K Doses)

Table 15. North America Chickenpox Vaccine Sales by Type (2018-2023) & (US$ Million)

Table 16. Europe Chickenpox Vaccine Sales (K Doses) by Type (2018-2023)

Table 17. Europe Chickenpox Vaccine Sales by Type (2018-2023) & (US$ Million)

Table 18. Asia-Pacific Chickenpox Vaccine Sales (K Doses) by Type (2018-2023)

Table 19. Asia-Pacific Chickenpox Vaccine Sales by Type (2018-2023) & (US$ Million)

Table 20. Latin America Chickenpox Vaccine Sales (K Doses) by Type (2018-2023)

Table 21. Latin America Chickenpox Vaccine Sales by Type (2018-2023) & (US$ Million)

Table 22. Middle East and Africa Chickenpox Vaccine Sales (K Doses) by Type (2018-2023)

Table 23. Middle East and Africa Chickenpox Vaccine Sales by Type (2018-2023) & (US$ Million)

Table 24. Global Chickenpox Vaccine Sales by Company (2018-2023) & (K Doses)

Table 25. Global Chickenpox Vaccine Sales Share by Company (2018-2023)

Table 26. Global Chickenpox Vaccine Revenue by Company (2018-2023) & (US$ Million)

Table 27. Global Chickenpox Vaccine Revenue Share by Company (2018-2023)

Table 28. Global Market Chickenpox Vaccine Price by Company (2018-2023) & (USD/Dose)

Table 29. Global Chickenpox Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 30. Global Chickenpox Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chickenpox Vaccine as of 2022)

Table 32. Date of Key Manufacturers Enter into Chickenpox Vaccine Market

Table 33. Key Manufacturers Chickenpox Vaccine Product Type

Table 34. Mergers & Acquisitions, Expansion Plans

Table 35. Global Chickenpox Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 36. Global Chickenpox Vaccine Sales by Region (2018-2023) & (K Doses)

Table 37. Global Chickenpox Vaccine Sales Market Share in Volume by Region (2018-2023)

Table 38. Global Chickenpox Vaccine Sales by Region (2018-2023) & (US$ Million)

Table 39. Global Chickenpox Vaccine Sales Market Share in Value by Region (2018-2023)

Table 40. Global Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 41. Global Chickenpox Vaccine Sales by Region (2024-2029) & (K Doses)

Table 42. Global Chickenpox Vaccine Sales Market Share in Volume by Region (2024-2029)

Table 43. Global Chickenpox Vaccine Sales by Region (2024-2029) & (US$ Million)

Table 44. Global Chickenpox Vaccine Sales Market Share in Value by Region (2024-2029)

Table 45. Global Chickenpox Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2029)

Table 46. Global Chickenpox Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 47. Global Chickenpox Vaccine Sales by Application (2018-2023) & (K Doses)

Table 48. Global Chickenpox Vaccine Sales Market Share in Volume by Application (2018-2023)

Table 49. Global Chickenpox Vaccine Sales by Application (2018-2023) & (US$ Million)

Table 50. Global Chickenpox Vaccine Sales Market Share in Value by Application (2018-2023)

Table 51. Global Chickenpox Vaccine Price by Application (2018-2023) & (USD/Dose)

Table 52. Global Chickenpox Vaccine Sales by Application (2024-2029) & (K Doses)

Table 53. Global Chickenpox Vaccine Sales Market Share in Volume by Application (2024-2029)

Table 54. Global Chickenpox Vaccine Sales by Application (2024-2029) & (US$ Million)

Table 55. Global Chickenpox Vaccine Sales Market Share in Value by Application (2024-2029)

Table 56. Global Chickenpox Vaccine Price by Application (2024-2029) & (USD/Dose)

Table 57. North America Chickenpox Vaccine Sales by Application (2018-2023) (K Doses)

Table 58. North America Chickenpox Vaccine Sales by Application (2018-2023) & (US$ Million)

Table 59. Europe Chickenpox Vaccine Sales by Application (2018-2023) (K Doses)

Table 60. Europe Chickenpox Vaccine Sales by Application (2018-2023) & (US$ Million)

Table 61. Asia-Pacific Chickenpox Vaccine Sales by Application (2018-2023) (K Doses)

Table 62. Asia-Pacific Chickenpox Vaccine Sales by Application (2018-2023) & (US$ Million)

Table 63. Latin America Chickenpox Vaccine Sales by Application (2018-2023) (K Doses)

Table 64. Latin America Chickenpox Vaccine Sales by Application (2018-2023) & (US$ Million)

Table 65. Middle East and Africa Chickenpox Vaccine Sales by Application (2018-2023) (K Doses)

Table 66. Middle East and Africa Chickenpox Vaccine Sales by Application (2018-2023) & (US$ Million)

Table 67. North America Chickenpox Vaccine Sales by Country (2018-2023) & (K Doses)

Table 68. North America Chickenpox Vaccine Sales Market Share in Volume by Country (2018-2023)

Table 69. North America Chickenpox Vaccine Sales by Country (2018-2023) & (US$ Million)

Table 70. North America Chickenpox Vaccine Sales Market Share in Value by Country (2018-2023)

Table 71. North America Chickenpox Vaccine Sales by Country (2024-2029) & (K Doses)

Table 72. North America Chickenpox Vaccine Sales Market Share in Volume by Country (2024-2029)

Table 73. North America Chickenpox Vaccine Sales by Country (2024-2029) & (US$ Million)

Table 74. North America Chickenpox Vaccine Sales Market Share in Value by Country (2024-2029)

Table 75. Europe Chickenpox Vaccine Sales by Country (2018-2023) & (K Doses)

Table 76. Europe Chickenpox Vaccine Sales Market Share in Volume by Country (2018-2023)

Table 77. Europe Chickenpox Vaccine Sales by Country (2018-2023) & (US$ Million)

Table 78. Europe Chickenpox Vaccine Sales Market Share in Value by Country (2018-2023)

Table 79. Europe Chickenpox Vaccine Sales by Country (2024-2029) & (K Doses)

Table 80. Europe Chickenpox Vaccine Sales Market Share in Volume by Country (2024-2029)

Table 81. Europe Chickenpox Vaccine Sales by Country (2024-2029) & (US$ Million)

Table 82. Europe Chickenpox Vaccine Sales Market Share in Value by Country (2024-2029)

Table 83. Asia-Pacific Chickenpox Vaccine Sales by Region (2018-2023) & (K Doses)

Table 84. Asia-Pacific Chickenpox Vaccine Sales Market Share in Volume by Region (2018-2023)

Table 85. Asia-Pacific Chickenpox Vaccine Sales by Region (2018-2023) & (US$ Million)

Table 86. Asia-Pacific Chickenpox Vaccine Sales Market Share in Value by Region (2018-2023)

Table 87. Asia-Pacific Chickenpox Vaccine Sales by Region (2024-2029) & (K Doses)

Table 88. Asia-Pacific Chickenpox Vaccine Sales Market Share in Volume by Region (2024-2029)

Table 89. Asia-Pacific Chickenpox Vaccine Sales by Region (2024-2029) & (US$ Million)

Table 90. Asia-Pacific Chickenpox Vaccine Sales Market Share in Value by Region (2024-2029)

Table 91. Latin America Chickenpox Vaccine Sales by Country (2018-2023) & (K Doses)

Table 92. Latin America Chickenpox Vaccine Sales Market Share in Volume by Country (2018-2023)

Table 93. Latin America Chickenpox Vaccine Sales by Country (2018-2023) & (US$ Million)

Table 94. Latin America Chickenpox Vaccine Sales Market Share in Value by Country (2018-2023)

Table 95. Latin America Chickenpox Vaccine Sales by Country (2024-2029) & (K Doses)

Table 96. Latin America Chickenpox Vaccine Sales Market Share in Volume by Country (2024-2029)

Table 97. Latin America Chickenpox Vaccine Sales by Country (2024-2029) & (US$ Million)

Table 98. Latin America Chickenpox Vaccine Sales Market Share in Value by Country (2024-2029)

Table 99. Middle East and Africa Chickenpox Vaccine Sales by Country (2018-2023) & (K Doses)

Table 100. Middle East and Africa Chickenpox Vaccine Sales Market Share in Volume by Country (2018-2023)

Table 101. Middle East and Africa Chickenpox Vaccine Sales by Country (2018-2023) & (US$ Million)

Table 102. Middle East and Africa Chickenpox Vaccine Sales Market Share in Value by Country (2018-2023)

Table 103. Middle East and Africa Chickenpox Vaccine Sales by Country (2024-2029) & (K Doses)

Table 104. Middle East and Africa Chickenpox Vaccine Sales Market Share in Volume by Country (2024-2029)

Table 105. Middle East and Africa Chickenpox Vaccine Sales by Country (2024-2029) & (US$ Million)

Table 106. Middle East and Africa Chickenpox Vaccine Sales Market Share in Value by Country (2024-2029)

Table 107. Merck Company Information

Table 108. Merck Introduction and Business Overview

Table 109. Merck Chickenpox Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 110. Merck Chickenpox Vaccine Product

Table 111. Merck Recent Development

Table 112. GSK Company Information

Table 113. GSK Introduction and Business Overview

Table 114. GSK Chickenpox Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 115. GSK Chickenpox Vaccine Product

Table 116. GSK Recent Development

Table 117. Shanghai Institute Company Information

Table 118. Shanghai Institute Introduction and Business Overview

Table 119. Shanghai Institute Chickenpox Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 120. Shanghai Institute Chickenpox Vaccine Product

Table 121. Shanghai Institute Recent Development

Table 122. BCHT Company Information

Table 123. BCHT Introduction and Business Overview

Table 124. BCHT Chickenpox Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 125. BCHT Chickenpox Vaccine Product

Table 126. BCHT Recent Development

Table 127. Changsheng Company Information

Table 128. Changsheng Introduction and Business Overview

Table 129. Changsheng Chickenpox Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 130. Changsheng Chickenpox Vaccine Product

Table 131. Changsheng Recent Development

Table 132. Keygen Company Information

Table 133. Keygen Introduction and Business Overview

Table 134. Keygen Chickenpox Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 135. Keygen Chickenpox Vaccine Product

Table 136. Keygen Recent Development

Table 137. Green Cross Company Information

Table 138. Green Cross Introduction and Business Overview

Table 139. Green Cross Chickenpox Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 140. Green Cross Chickenpox Vaccine Product

Table 141. Green Cross Recent Development

Table 142. Biken Company Information

Table 143. Biken Introduction and Business Overview

Table 144. Biken Chickenpox Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2023)

Table 145. Biken Chickenpox Vaccine Product

Table 146. Biken Recent Development

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Chickenpox Vaccine Market Trends

Table 150. Chickenpox Vaccine Market Drivers

Table 151. Chickenpox Vaccine Market Challenges

Table 152. Chickenpox Vaccine Market Restraints

Table 153. Chickenpox Vaccine Distributors List

Table 154. Chickenpox Vaccine Downstream Customers

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

List of Figures

Figure 1. Chickenpox Vaccine Product Picture

Figure 2. Global Chickenpox Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Chickenpox Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Chickenpox Vaccine Sales Status and Outlook (2018-2029) & (K Doses)

Figure 5. Product Picture of Monovalent Vaccine

Figure 6. Global Monovalent Vaccine Sales YoY Growth (2018-2029) & (K Doses)

Figure 7. Product Picture of Combination Vaccine

Figure 8. Global Combination Vaccine Sales YoY Growth (2018-2029) & (K Doses)

Figure 9. Global Chickenpox Vaccine Sales by Type (2018-2029) & (US$ Million)

Figure 10. Global Chickenpox Vaccine Sales Market Share by Type in 2022 & 2029

Figure 11. North America Chickenpox Vaccine Sales Market Share in Volume by Type in 2022

Figure 12. North America Chickenpox Vaccine Sales Market Share in Value by Type in 2022

Figure 13. Europe Chickenpox Vaccine Sales Market Share in Volume by Type in 2022

Figure 14. Europe Chickenpox Vaccine Sales Market Share in Value by Type in 2022

Figure 15. Asia-Pacific Chickenpox Vaccine Sales Market Share in Volume by Type in 2022

Figure 16. Asia-Pacific Chickenpox Vaccine Sales Market Share in Value by Type in 2022

Figure 17. Latin America Chickenpox Vaccine Sales Market Share in Volume by Type in 2022

Figure 18. Latin America Chickenpox Vaccine Sales Market Share in Value by Type in 2022

Figure 19. Middle East and Africa Chickenpox Vaccine Sales Market Share in Volume by Type in 2022

Figure 20. Middle East and Africa Chickenpox Vaccine Sales Market Share in Value by Type in 2022

Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Chickenpox Vaccine Sales in 2022

Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Chickenpox Vaccine Revenue in 2022

Figure 23. Chickenpox Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 24. Product Picture of Kids Injection

Figure 25. Global Kids Injection Sales YoY Growth (2018-2029) & (K Doses)

Figure 26. Product Picture of Adults Injection

Figure 27. Global Adults Injection Sales YoY Growth (2018-2029) & (K Doses)

Figure 28. Global Chickenpox Vaccine Sales by Application (2018-2029) & (US$ Million)

Figure 29. Global Chickenpox Vaccine Sales Market Share by Application in 2022 & 2029

Figure 30. North America Chickenpox Vaccine Sales Market Share in Volume by Application in 2022

Figure 31. North America Chickenpox Vaccine Sales Market Share in Value by Application in 2022

Figure 32. Europe Chickenpox Vaccine Sales Market Share in Volume by Application in 2022

Figure 33. Europe Chickenpox Vaccine Sales Market Share in Value by Application in 2022

Figure 34. Asia-Pacific Chickenpox Vaccine Sales Market Share in Volume by Application in 2022

Figure 35. Asia-Pacific Chickenpox Vaccine Sales Market Share in Value by Application in 2022

Figure 36. Latin America Chickenpox Vaccine Sales Market Share in Volume by Application in 2022

Figure 37. Latin America Chickenpox Vaccine Sales Market Share in Value by Application in 2022

Figure 38. Middle East and Africa Chickenpox Vaccine Sales Market Share in Value by Application in 2022

Figure 39. Key Raw Materials Price

Figure 40. Chickenpox Vaccine Manufacturing Cost Structure

Figure 41. Chickenpox Vaccine Industrial Chain Analysis

Figure 42. Channels of Distribution

Figure 43. Distributors Profiles

Figure 44. Bottom-up and Top-down Approaches for This Report

Figure 45. Data Triangulation

Figure 46. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions